Zendia conducts clinical validation in Angola
In May and June 2025, Zendia successfully conducted clinical studies in Luanda, Angola, in collaboration with Prof. Miguel Brito from…
ZENDIA CONDUCTS SECOND INFECTOTEST® FEASIBILITY STUDY IN KYENJOJO, UGANDA
Together with Dr Gerald Tumussime and his team in Uganda, Zendia GmbH goes back to the district of Kyenjojo to get clinical data on the real world sensitivity of InfectoTest® on a particular population
Zendia Embarks on First InfectoTest® Feasibility Study in Kampala, Uganda
Zendia GmbH proudly launched its first field feasibility study, a collaboration with the medical faculty at Ugandan Christian University Under the expert guidance of Dr Gerald Tumussime and his dedicated team in Kampala, this study marks a significant milestone for InfectoTest®
Ethical Committee Endorses Zendia’s Study Protocol for Rapid Malaria Diagnostics
Zendia GmbH received feedback from the ethical committee from the Landesärztekammer Baden Württemberg regarding the submission of the Study Protocol…
Publication alert!
Today we published our work on the interactions of the Plasmodium falciparum parasite when confronted with hemolytic agents. This was…